Blood Test
Novel blood test shows promising accuracy for detection of early-stage pancreatic cancer
A next-generation biomarker-based blood test demonstrated 98% specificity and 75% sensitivity in detecting stage I and II pancreatic ductal adenocarcinoma, according to a press release from the manufacturer.
LuGENE blood test for lupus flares, drug targets enters open-label study
LuGENE, a blood test to predict lupus flares and quickly identify drug targets, is being made available to patients around the United States through an open-label study, according to a press release from the manufacturer.
Blood sample test can diagnose fibromyalgia via Raman spectroscopy
A blood sample analysis using Raman spectroscopy, combined with statistical modeling, was sufficient to diagnose fibromyalgia, according to data published in Biomedicines.
VIDEO: The best screening test for colorectal cancer is ‘the one that gets done’
In this Healio video exclusive, Sudha Pandit, MD, reports that the survival rate for colorectal cancer “is over 91%” if caught early, an important reminder during Colorectal Cancer Awareness Month.
Blood-based test detects CRC with 83% sensitivity, ‘could help overcome’ screening barriers
A cell-free DNA blood-based test detected colorectal cancer with a sensitivity of 83% and a specificity of 90% for advanced neoplasia in an average-risk population, according to new data published in The New England Journal of Medicine.
Partners in precision: PrismRA now available via ‘thousands’ of Quest collection sites
Precision medicine in rheumatoid arthritis expanded in a small but key measure late last year, when Quest Diagnostics and Scipher Medicine announced a partnership to provide RNA extraction and sequencing services for the latter’s PrismRA test.
FDA grants breakthrough device designation to blood-based Alzheimer’s diagnostic assay
The FDA has granted breakthrough device designation to a phospho-tau 217 blood-based biomarker to assist in the diagnosis of Alzheimer’s disease, according to the manufacturer.
Quanterix announces collaboration with health care groups to expand access to AD testing
Quanterix Corp. has announced collaborations with several health systems with the goal of improving and simplifying Alzheimer’s disease diagnosis by expanding access to blood biomarker assays.
Blood test demonstrates high accuracy in identifying sarcoidosis
A blood test was capable of distinguishing sarcoidosis from other respiratory diseases using disease-specific antigen biomarkers/epitopes, according to results published in American Journal of Respiratory and Critical Care Medicine.
Multivariable blood test identifies aggressive prostate cancer more accurately than PSA
The Stockholm3 multivariable blood test demonstrated superior specificity of prostate cancer detection across a diverse population compared with PSA screening, according to findings presented at ASCO Genitourinary Cancers Symposium.